Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 324

Sort by

Sort Order Select

Journal Articles

Abnormalities Detected By Array CGH and Fluorescence in Situ Hybridization in AML with Normal Karyotype Lacking Mutations in NPM1 , CEBPA , RUNX1 and MLL Partial Tandem Duplications Are Associated with Unfavorable Outcome

Claudia Haferlach, MD, Kathleen Zieschang, Susanne Schnittger, PhD, Tamara Alpermann, Melanie Zenger, Karolína Perglerová, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 1371.

https://doi.org/10.1182/blood.V126.23.1371.1371

Published: 2015

Journal Articles

BAALC Expression Is a Feasible Marker for Risk Stratification and Detection of Minimal Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

Simone Weber, Tamara Alpermann, Karolína Perglerová, Susanne Schnittger, PhD, Torsten Haferlach, Claudia Haferlach, MD, Wolfgang Kern, MD

Blood (2015) 126 (23): 1373.

https://doi.org/10.1182/blood.V126.23.1373.1373

Published: 2015

Journal Articles

Three Steps to the Diagnosis of Adult Ph-like ALL

Annette Fasan, PhD, Wolfgang Kern, MD, Niroshan Nadarajah, M.Sc., Simone Weber, Sonja Schindela, Nicole Schlenther, Susanne Schnittger, PhD, Torsten Haferlach, Claudia Haferlach, MD

Blood (2015) 126 (23): 2610.

https://doi.org/10.1182/blood.V126.23.2610.2610

Published: 2015

Journal Articles

Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM - Rara , CBFB - MYH11 , and RUNX1 - RUNX1T1 : A Study on 600 Patients

Torsten Haferlach, Manja Meggendorfer, PhD, Susanne Schnittger, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2015) 126 (23): 228.

https://doi.org/10.1182/blood.V126.23.228.228

Published: 2015

Journal Articles

Myeloid Nuclear Differentiation Antigen (MNDA) Expression: A Useful Marker in the Diagnosis of Myelodysplastic Syndromes By Flow Cytometry

Frauke Bellos, MD, Torsten Haferlach, Bruce H. Davis, MD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD

Blood (2015) 126 (23): 5235.

https://doi.org/10.1182/blood.V126.23.5235.5235

Published: 2015

Journal Articles

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 5205.

https://doi.org/10.1182/blood.V126.23.5205.5205

Published: 2015

Journal Articles

Characterization of Del(14)(q24q32) in Mature B-Cell Neoplasms By Array-CGH, Cytogenetics and Molecular Mutations

Sabine Jeromin, PhD, Wolfgang Kern, MD, Torsten Haferlach, Susanne Schnittger, PhD, Claudia Haferlach, MD

Blood (2015) 126 (23): 3901.

https://doi.org/10.1182/blood.V126.23.3901.3901

Published: 2015

Journal Articles

Does Age of Patients Influence the Composition of Gene Mutations in Myeloid Neoplasms?

Manja Meggendorfer, PhD, Wolfgang Kern, MD, Karolína Perglerová, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach

Blood (2015) 126 (23): 3821.

https://doi.org/10.1182/blood.V126.23.3821.3821

Published: 2015

Journal Articles

Comparison of TP53 Alterations in Hematological Malignancies

Anna Stengel, PhD, Wolfgang Kern, MD, Torsten Haferlach, Susanne Schnittger, PhD, Melanie Zenger, Claudia Haferlach, MD

Blood (2015) 126 (23): 4819.

https://doi.org/10.1182/blood.V126.23.4819.4819

Published: 2015

Journal Articles

Molecular Characterization of Philadelphia Chromosome Positive Acute Myeloid Leukemia - New Provisional Entity?

Simone Weber, Manja Meggendorfer, PhD, Niroshan Nadarajah, M.Sc., Karolína Perglerová, Susanne Schnittger, PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 3846.

https://doi.org/10.1182/blood.V126.23.3846.3846

Published: 2015

Journal Articles

Myeloid Malignancies with Isolated 7q Deletion Can be Further Characterized By Their Accompanying Molecular Mutations

Claudia Haferlach, MD, Annette Fasan, PhD, Manja Meggendorfer, PhD, Melanie Zenger, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 3811.

https://doi.org/10.1182/blood.V126.23.3811.3811

Published: 2015

Journal Articles

Landscape of Secondary Genetic Lesions in Acute Myeloid Leukemia with Inv(16)/ CBFB-MYH11

Annette Fasan, PhD, Claudia Haferlach, MD, Karolína Perglerová, Sonja Schindela, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 801.

https://doi.org/10.1182/blood.V126.23.801.801

Published: 2015

Journal Articles

Additional Mutations in SRSF2, ASXL1 and/or RUNX1 Identify a High Risk Group of Patients with KIT D816V + Advanced Systemic Mastocytosis

Mohamad Jawhar, Juliana Schwaab, MD, Susanne Schnittger, PhD, Manja Meggendorfer, PhD, Karl Sotlar, MD, Hans-Peter Horny, MD, Georgia Metzgeroth, MD, Sebastian Kluger, Nicole Naumann, Claudia Haferlach, MD, Torsten Haferlach, Peter Valent, MD, Wolf-Karsten Hofmann, MD, Alice Charlotte Fabarius, PhD, Nicholas C.P. Cross, PhD, Andreas Reiter, MD

Blood (2015) 126 (23): 349.

https://doi.org/10.1182/blood.V126.23.349.349

Published: 2015

Journal Articles

AML with RUNX1 Mutations and Loss of RUNX1 Wild-Type - a Distinct Subset?

Claudia Haferlach, MD, Niroshan Nadarajah, M.Sc., Annette Fasan, PhD, Karolína Perglerová, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 2578.

https://doi.org/10.1182/blood.V126.23.2578.2578

Published: 2015

Journal Articles

Correlation of CD30 Expression on Neoplastic Mast Cells in Systemic Mastocytosis Assessed By Immunohistochemistry Versus Multiparameter Flow Cytometry and Correlation to Clinical Parameters

Frauke Bellos, MD, Karl Sotlar, MD, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach, Wolfgang Kern, MD

Blood (2015) 126 (23): 1616.

https://doi.org/10.1182/blood.V126.23.1616.1616

Published: 2015

Journal Articles

In Depth Characterization of CLL with Normal Karyotype By Array CGH and Mutation Screening

Claudia Haferlach, MD, Sabine Jeromin, PhD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 1707.

https://doi.org/10.1182/blood.V126.23.1707.1707

Published: 2015

Journal Articles

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Christian T. Dietz, PhD, Alice Charlotte Fabarius, PhD, Michael Lauseker, PhD, Susanne Saussele, Lida Kalmanti, Sébastien Rinaldetti, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martine Jotterand, Alois Gratwohl, Axel R. Zander, Professor, Nicolaus Kröger, Dietrich W. Beelen, MD, Jürgen Novotny, Christoph Nerl, Christof Scheid, MD PhD, Karsten Spiekermann, Jiri Mayer, MD, Herbert G. Sayer, Christiane Falge, Donald Bunjes, MD, Hartmut Döhner, Prof. Dr., Arnold Ganser, Peter Brossart, MD, Rainer Schwerdtfeger, Herrad Baumann, Rolf Kuse, Hans Walter Lindemann, MD, Matthias Bormann, Bernd Hertenstein, MD, Gabriela M. Baerlocher, Carlo Aul, MD, Peter Staib, Matthias Edinger, MD, Michael Schatz, Axel A Fauser, Renate Arnold, MD, Dieter K. Hossfeld, MD, Hans-Jochem Kolb, Susanne Schnittger, PhD, Martin C. Müller, MD, Andreas Reiter, MD, Andreas Hochhaus, MD, Markus Pfirrmann, Joerg Hasford, Michele Baccarani, Ruediger Hehlmann, MD

Blood (2015) 126 (23): 1581.

https://doi.org/10.1182/blood.V126.23.1581.1581

Published: 2015

Journal Articles

Significance of Flow Cytometric and Mutational Findings in Patients with Cytopenias and Limited or No Signs of Myelodysplasia By Cytomorphology

Wolfgang Kern, MD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 1671.

https://doi.org/10.1182/blood.V126.23.1671.1671

Published: 2015

Journal Articles

Characterization of CMML with Normal Karyotype in Comparison to CMML with Aberrant Karyotype

Claudia Haferlach, MD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 1674.

https://doi.org/10.1182/blood.V126.23.1674.1674

Published: 2015

Journal Articles

Modulation of the Clonal Composition in Relapsed CLL: A Study Based on Targeted Deep-Sequencing of ATM, BIRC3, NOTCH1, POT1, SF3B1, SAMHD1 and TP53

Sabine Jeromin, PhD, Wolfgang Kern, MD, Richard Schabath, Tamara Alpermann, Niroshan Nadarajah, M.Sc., Manja Meggendorfer, PhD, Susanne Schnittger, PhD, Torsten Haferlach, Claudia Haferlach, MD

Blood (2015) 126 (23): 1721.

https://doi.org/10.1182/blood.V126.23.1721.1721

Published: 2015

NARROW

Abnormalities Detected By Array CGH and Fluorescence in Situ Hybridization in AML with Normal Karyotype Lacking Mutations in NPM1 , CEBPA , RUNX1 and MLL Partial Tandem Duplications Are Associated with Unfavorable Outcome

BAALC Expression Is a Feasible Marker for Risk Stratification and Detection of Minimal Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

Three Steps to the Diagnosis of Adult Ph-like ALL

Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM - Rara , CBFB - MYH11 , and RUNX1 - RUNX1T1 : A Study on 600 Patients

Myeloid Nuclear Differentiation Antigen (MNDA) Expression: A Useful Marker in the Diagnosis of Myelodysplastic Syndromes By Flow Cytometry

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Characterization of Del(14)(q24q32) in Mature B-Cell Neoplasms By Array-CGH, Cytogenetics and Molecular Mutations

Does Age of Patients Influence the Composition of Gene Mutations in Myeloid Neoplasms?

Comparison of TP53 Alterations in Hematological Malignancies

Molecular Characterization of Philadelphia Chromosome Positive Acute Myeloid Leukemia - New Provisional Entity?

Myeloid Malignancies with Isolated 7q Deletion Can be Further Characterized By Their Accompanying Molecular Mutations

Landscape of Secondary Genetic Lesions in Acute Myeloid Leukemia with Inv(16)/ CBFB-MYH11

Additional Mutations in SRSF2, ASXL1 and/or RUNX1 Identify a High Risk Group of Patients with KIT D816V + Advanced Systemic Mastocytosis

AML with RUNX1 Mutations and Loss of RUNX1 Wild-Type - a Distinct Subset?

Correlation of CD30 Expression on Neoplastic Mast Cells in Systemic Mastocytosis Assessed By Immunohistochemistry Versus Multiparameter Flow Cytometry and Correlation to Clinical Parameters

In Depth Characterization of CLL with Normal Karyotype By Array CGH and Mutation Screening

Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA

Significance of Flow Cytometric and Mutational Findings in Patients with Cytopenias and Limited or No Signs of Myelodysplasia By Cytomorphology

Characterization of CMML with Normal Karyotype in Comparison to CMML with Aberrant Karyotype

Modulation of the Clonal Composition in Relapsed CLL: A Study Based on Targeted Deep-Sequencing of ATM, BIRC3, NOTCH1, POT1, SF3B1, SAMHD1 and TP53

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only